The use of, and outcomes for, inflammatory bowel disease services during the Covid-19 pandemic: a nationwide observational studyObservational Study Published on 2022-04-012022-10-05 Journal: Alimentary pharmacology & therapeutics [Category] 임상, [키워드] 30-Day mortality acute ulcerative colitis Admission affected average bowel Care Cohort Community COVID-19 Crohn’s disease decrease Delay disease England estimates exacerbated hospital IBD Inflammatory bowel disease median outcome pandemic Prevalence Quality of life readmission reduction secondary care significant difference surgery Treatment ulcerative colitis Volume [DOI] 10.1111/apt.16800 PMC 바로가기 [Article Type] Observational Study
Molecular mechanisms of Huanglian jiedu decoction on ulcerative colitis based on network pharmacology and molecular docking Research Published on 2022-04-012022-10-05 Journal: Scientific Reports [Category] 바이오마커, [키워드] Analysis BCI binding ability candidate drug Cell Chinese component composed core gene docked IL-17 IMPROVE Inflammatory response intestinal involved KEGG maintain mechanism molecular docking molecular mechanism network pharmacology pathway pharmacological PPI network previous study Regulation shown target target gene TNF Treatment ulcerative colitis [DOI] 10.1038/s41598-022-09559-1 [Article Type] Research
Comparative effectiveness of second-line biological therapies for ulcerative colitis and Crohn’s disease in patients with prior failure of anti-tumour necrosis factor treatmentarticle Published on 2022-03-272024-09-02 Journal: BMC Gastroenterology [Category] 대상포진, [키워드] anti-TNF therapy Crohn’s disease Tofacitinib ulcerative colitis ustekinumab vedolizumab [DOI] 10.1186/s12876-022-02225-w PMC 바로가기 [Article Type] article
Case Report: Pneumonia in a Patient With Combined Variable Immunodeficiency: COVID-19 or Pneumocystis Pneumonia?Medicine Published on 2022-02-232022-10-31 Journal: Frontiers in Medicine [Category] COVID-19, [키워드] added Case report characterized chest CT scan clinical condition Combined common variable immunodeficiency (CVID) Consequences cough COVID-19 COVID-19 epidemic CVID Diagnosis diagnosis of COVID-19 discharged disorder DNA Dyspnea Evidence febrile patient Fever High-dose hospital hypersensitive immune system Immunocompromised patients immunodeficiency impairment life-threatening manifestation Manifestations methodology opportunistic infection opportunistic Infections Patient PCR physician pneumocystis pneumonia Pneumomediastinum Pneumonia polymerase chain radiological respiratory specimens respiratory symptoms respond SARS-CoV-2 susceptible the patient treated Treatment ulcerative colitis variable [DOI] 10.3389/fmed.2022.814300 PMC 바로가기 [Article Type] Medicine
A Randomized Placebo-Controlled Trial of Combination Therapy With Post-triple-antibiotic-therapy Fecal Microbiota Transplantation and Alginate for Ulcerative Colitis: ProtocolArticle Published on 2022-02-222023-08-30 Journal: Frontiers in Medicine [Category] E형 간염, [키워드] alginate antibiotic-FMT double-blind randomized controlled trial fecal microbiota transplantation (FMT) placebo-controlled clinical study ulcerative colitis [DOI] 10.3389/fmed.2022.779205 PMC 바로가기
Donor Screening Revisions of Fecal Microbiota Transplantation in Patients with Ulcerative ColitisArticle Published on 2022-02-172023-08-30 Journal: Journal of Clinical Medicine [Category] E형 간염, [키워드] donor screening fecal microbiota transplantation ulcerative colitis [DOI] 10.3390/jcm11041055 PMC 바로가기 [Article Type] Article
A more frequent disease monitorering but no increased disease activity in patients with inflammatory bowel disease during the first year of the SARS-CoV-2 pandemic. A retrospective studyArticle Published on 2022-02-012023-07-06 Journal: Scandinavian journal of gastroenterology [Category] COVID19(2023년), [키워드] calprotectin COVID-19 Crohn’s disease Inflammatory bowel disease SARS-CoV-2 Telemedicine ulcerative colitis [DOI] 10.1080/00365521.2021.1993328
Initial experience of tofacitinib for treating refractory moderate-to-severe ulcerative colitisCase Report Published on 2022-02-012024-09-04 Journal: Nagoya journal of medical science [Category] 대상포진, [키워드] case reports refractory Tofacitinib ulcerative colitis [DOI] 10.18999/nagjms.84.1.169 PMC 바로가기 [Article Type] Case Report
SARS-CoV-2 (COVID-19) pneumonia patient treated with two doses of infliximab within 2 weeks for acute severe ulcerative colitis A case reportSARS-CoV-2(COVID-19) 폐렴 환자, 급성 중증 궤양성 대장염 2주 이내 인플릭시맙 2회 투여 증례 보고Case Reports Published on 2022-01-282022-09-12 Journal: Medicine [Category] 진단, [키워드] abdominal pain acute COVID-19 acute respiratory syndrome Administered an infectious disease caused by the SARS-CoV-2 virus anti-TNF anti-TNF-α azathioprine bleeding bloody can be used Case report caused Clostridium difficile Colitis Colon complications coronavirus Corticosteroid Corticosteroids COVID-19 COVID-19 infection COVID-19 patient COVID-19 symptom COVID-19 symptoms current cytomegalovirus deteriorate diagnosed diagnosis of COVID-19 diarrhea dose Fever Immune-mediated inflammatory diseases Immunosuppressant immunosuppressants Immunotherapy IMPROVE induce Infection Infectious disease Inflammatory diseases infliximab inhibitor intravenous Loading dose male mesalamine Nasopharyngeal swab Necrosis necrosis factor antagonists nine outcomes pandemic Patient Pneumonia positive receiving Remission Research SARS-CoV-2 SARS-CoV-2 virus Severe acute respiratory syndrome Sigmoidoscopy spontaneous bleeding surgery tested the SARS-CoV-2 virus therapy treated Treatment Tumor tumor necrosis tumor necrosis factor ulcerative colitis [DOI] 10.1097/MD.0000000000028722 PMC 바로가기 [Article Type] Case Reports
Real-World Use and Adverse Events of SARS-CoV-2 Vaccination in Greek Patients with Inflammatory Bowel DiseaseArticle Published on 2022-01-272022-10-30 Journal: Journal of Clinical Medicine [Category] COVID-19, [키워드] abdominal pain Adverse adverse event AEs age Analysis Clinical characteristics concerning COVID-19 COVID-19 vaccination COVID-19 vaccine Crohn’s disease demographics demonstrated diarrhea disease dose doses Effect female gender Hospitalization IBD inactive Inflammatory bowel disease information injection knowledge Occurrence Patient patients reaction reported safety profile SARS-CoV-2 SARS-CoV-2 vaccination serious AE Symptom systemic Total Treatment ulcerative colitis vaccination Vaccine were excluded [DOI] 10.3390/jcm11030641 PMC 바로가기 [Article Type] Article